Brief: Kiromic Announces Filing Of Key European Patents For Its Chimeric Pd-1 (chPD1) Target
05/01/2021 02:08
Jan 4 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC ANNOUNCES FILING OF KEY EUROPEAN PATENTS FOR ITS
CHIMERIC PD-1 (CHPD1) TARGET
Source text for Eikon: ID:nBw6ZbNgta
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site